An interventional study of Instrumented Stair Climb Test and Walk Test in Stair Climbing, Instrumentation and Test, sponsored by IRCCS Eugenio Medea. Recruiting at 3 sites in Italy. Open to participants aged 4 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-02-27.
Sponsored by IRCCS Eugenio Medea · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 18 studies in Cerebral Palsy by IRCCS Eugenio Medea — 8 open to participants now, 8 under way, none of them phase 3. Cerebral Palsy · IRCCS Eugenio Medea.
Among the 18 studies in Cerebral Palsy by IRCCS Eugenio Medea, this one is the 2nd largest by planned enrollment of the 11 interventional ones that give a count, is the only one that started in 2025, is one of 11 with no phase, and was the 17th registered.
1,942 studies on the registry are indexed under Cerebral Palsy; 456 are open to participants now.
Browse Cerebral Palsy studies →8 of the 18 studies in Cerebral Palsy by IRCCS Eugenio Medea are open now, in 1 country. Recruiting first, the newest first:
IRCCS Eugenio Medea · Sites in Italy
Ages 6–14
IRCCS Eugenio Medea · Sites in Italy
Ages 8–17 · Healthy volunteers
IRCCS Eugenio Medea · Sites in Italy
Ages 5–17
IRCCS Eugenio Medea · Sites in Italy
Ages 36 mo–5 yrs
IRCCS Eugenio Medea · Sites in Italy
Ages 5–20
By country, each count listing its studies:
Of the 271 Cerebral Palsy studies recruiting now, 26 (10%) set no upper age limit and 237 (87%) stop at 75 or younger; 256 take children under 18; 53 take healthy volunteers.
This study: 4 Years to 80 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
18 studies; the count open now beside each. This study's row is marked.
First in 2016; this study’s year is marked. 1 started in 2025.
This study's planned enrollment of 64 is above the median of 34 across 1,434 interventional studies indexed under Cerebral Palsy.
Median enrollment 44 across the 11 interventional studies, 59 across the 7 observational. Of the 10 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
IRCCS Eugenio Medea is the lead sponsor of 109 studies on the registry; 52 are open to participants now.
1 of the studies in Cerebral Palsy by IRCCS Eugenio Medea that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06622655IRCCS Eugenio MedeaClinical Improvement Due to the Home Use of Agilik in Children With Cerebral Palsy | 2026-11 |
Add it to your calendar (.ics) → With an account.
Among the 18 studies in Cerebral Palsy by IRCCS Eugenio Medea, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The aim of this study is to design an instrumented test for the evaluation of the climb of stairs. In particular, the main purpose is to characterize and compare the performance of subjects, both pediatrics and adults, with different pathologies (cerebral palsy, amputee, Parkinson's disease, stroke and arthroplasty) in carrying out the instrumented test of climbing and descending stairs. This would provide potentially useful information to complement the clinical assessment, including investigating the existence of correlations between the instrumental data obtained and the clinical scales collected. The secondary objective is to evaluate, in a first phase of the study, the feasibility and reliability of the test, analyzing the validity of the indices obtained in terms of intra- and inter-operator reliability on healthy subjects.
In today's clinical practice there are several assessment tools available to measure strength, endurance and balance. These tools include manual testing, standardised measurement scales or disease-specific scoring systems in which the results obtained during the performance of different motor tasks are calculated to obtain an overall score reflecting the functional level. Among the most used tests, for example, we remember the Six Minute Walking Test, in which the maximum distance walked, expressed in meters, is measured in a time of 6 minutes under standardized conditions, allowing the evaluation of muscular endurance and gait aspects. In addition to tests that monitor walking abilities, there are tests for more complex activities such as climbing and descending stairs. The ability to climb stairs, in contrast to flat walking, can be considered a more challenging task, as it places greater emphasis on muscle strength of lower limbs, requires a greater range of motion of the lower limb joints and increases the demand for posture control and balance system. In addition, falls from stairs can cause more serious injury or even death than falls on a floor. Therefore, for patients with a higher risk of falling, an objective assessment of the performance of climbing stairs could be of great interest, providing fundamental support in managing the activities of the patient's daily life. In the past, a number of methods and technologies have been proposed to analyse and quantify human gait. Measurement systems range from optoelectronic systems, pressure pads or force plates to mobile sensors worn on the body such as inertial units (IMUs) or pressure pads. Mobile gait analysis systems based on IMU, in particular, are attracting increasing interest for use in long-term assessments that can be easily performed in clinical practice. Similarly, inertial sensors could be adopted for an objective evaluation of the ascent and descent of ladders thanks to adapted step analysis algorithms capable of segmenting, parameterizing and classifying the ascent and descent of ladders. The aim of this study, therefore, is to design a test for the evaluation of climbing stairs based on the use of wearable sensors. In particular, the main objective will be to characterise and compare the performance of subjects with different pathologies, providing potentially useful information to complement clinical evaluation. The secondary objective of the study will be to analyse the reliability of the indices obtained. This work proposal is the result of collaboration between several centres: IRCCS E. Medea, IRCCS Istituti Clinici Maugeri Tradate, Pio Albergo Trivulzio and Politecnico di Milano. In particular, IRCCS E. Medea, IRCCS Istituti Clinici Maugeri Tradate and Pio Albergo Trivulzio will be responsible for the recruitment of subjects and data collection. These centres will have the support of the Politecnico di Milano for the processing of data and for the development of the algorithms necessary for the extraction of the monitored parameters from the devices used.
Common inclusion criteria for all groups:
- Ability to climb and descend 10 steps with supervision, even with handrail support.
Common exclusion criteria for all groups:
Inclusion criteria for the healthy group :
Inclusion criteria for the PCI group :
Inclusion criteria for the Orthopaedic group:
Inclusion criteria for the Amputee group:
Inclusion criteria for the Parkinson's group:
Inclusion criteria for the group Ictus Cerebri:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The New York Heart Association’s four classes of how much heart failure limits physical activity.
Studies set their own limit — many outside heart failure leave out class III–IV, while heart failure studies may ask for a particular class. Check the class this study names.
NYHA class (heart failure)
The New York Heart Association’s four classes of how much heart failure limits physical activity.
Studies set their own limit — many outside heart failure leave out class III–IV, while heart failure studies may ask for a particular class. Check the class this study names.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
This group involves healthy children aged 4-18 years old, without gait impairmets
Other: Walk Test · Other: Repaeted Instrumented Stair Climb Test
This group involves healthy adults aged 18-65 years old, without gait impairmets
Other: Walk Test · Other: Repaeted Instrumented Stair Climb Test
This group involves healthy eleferly aged 65-85 years old, without gait impairmets
Other: Walk Test · Other: Repaeted Instrumented Stair Climb Test
pediatric subjects diagnosed with Infantile Cerebral Paralysis (PCI) and clinical sign of left or right hemiparesis;
Other: Instrumented Stair Climb Test · Other: Walk Test
Patients aged 19-80 years, with results of leg amputation (transtibial), who carry limb prostheses
Other: Instrumented Stair Climb Test · Other: Walk Test
patients aged 65-80 years, with aftereffects of hip or knee arthroplasty, excluding prosthetic revision procedures
Other: Instrumented Stair Climb Test · Other: Walk Test
atients aged 65-80 years, with diagnosis of Parkinson's disease or Parkinsonism even on a vascular basis
Other: Instrumented Stair Climb Test · Other: Walk Test
Patients aged 65-80 years, with aftereffects of Cerebral Stroke with left or right hemiparesis
Other: Instrumented Stair Climb Test · Other: Walk Test
Instrumented test of climbing and descending stairs for the evaluation of kinematic and electromyographic variables. The test consists of repeating the ascent and descent of a flight of 10-12 steps;
Assessment of climbing and walking skills through test series: Borg scale: An evaluation scale for measuring effort perception. The evaluation scale consists of answering some questions at the end of the exercise described above; 10-metre walk test (10MWT): Test to assess walking speed in metres per second over a short distance. Can be used to determine functional mobility, gait and vestibular function. The test consists of walking at a steady speed and safely for 10 metres; 30 second sit to stand test: test for the evaluation of strength and endurance of the legs in the elderly. The test consists in performing the movement of standing up and sitting down from a chair for 30 consecutive seconds; Timed Up \& Go test (TUG): test to assess the risk of falling and balance. During the test, patients wear normal footwear and may use a walking aid if necessary. The patient starts in a sitting position, gets up on the therapist's command, walks in a straight line for a distance of 3 m
Instrumented test of climbing and descending stairs for the evaluation of kinematic and electromyographic variables. The test consists of repeating the ascent and descent of a flight of 10-12 steps. In this case, the ascent and descent of the stairs must be repeated two times. Between the two trial the IMU units must be repositioned.
Absolue error automatic test time
Absolute errors were calculated for the duration time of the stair ascent and descent and for each variable by taking the absolute value after subtracting the values obtained using IMU methods from the value measured using the tradional chronometer method
Time frame: Through study completion, an average of 1 year
Intra - inter operator variability
To ensure consistency between the data obtained by the IMU method and the data obtained by the traditional chronometric method, the investigators first calculated the normality of the data. The two-way mixed effects model, absolute agreement, and average measurements were used to calculate the ICCs between the duration time of both systems in case of normality. Instead, the Sperman test was used by the investigator if the data had a non-normal distribution
Time frame: Through study completion, an average of 1 year
correlations with Ten meters Walk Test (10mWT)
The investigators determine if there are any correlations between the instrumental data gathered from a test performed using the IMU method and the clinical test of the Ten meters walking test (10mWT). In the 10mWT the total time taken to ambulate 6 meters (m) is recorded to the nearest hundredth of a second. 6 m is then divided by the total time (in seconds) taken to ambulate and recorded in m/s.
Time frame: Through study completion, an average of 1 year
correlations with 30 seconds chair to stand test
The investigators determine if there are any correlations between the instrumental data gathered from a test performed using the IMU method and the clinical test of the 30 seconds chair to stand test. The test score is the total number of lifts completed in 30 seconds. During the test, the participant can stop and rest if he is tired without stopping time. If a person fails to perform any high the score for the test is zero
Time frame: Through study completion, an average of 1 year
correlations with Timed Up and Go (TUG)
The investigators determine if there are any correlations between the instrumental data gathered from a test performed using the IMU method and the clinical test Timed Up and Go test (TuG). The score in the text corresponds to the time taken by the participants to get up, walk to a distance of 3 m, turn around and return to their seats. Regular walking aids are permitted and recorded if necessary.
Time frame: Through study completion, an average of 1 year
correlations with Borg Scale
The investigators determine if there are any correlations between the instrumental data gathered from a test performed using the IMU method and the clinical Borg Scale. This is a scale to assess the intensity of exercise without having to rely on physiological parameters. The original Borg version is a scale of 6-20.
Time frame: Through study completion, an average of 1 year
Started Apr 2025 (actual). Primary completion is estimated for Apr 2026, 12 months after the start.
Of 906 non-industry interventional studies with no phase under Cerebral Palsy, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 31. This study's planned 12 months is close to that.
Counting every sponsor, half of 925 studies reached it within 12 months; a quarter within 5 and three quarters within 31.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.